MedTech Innovator is accepting applications for its five-month 2027 accelerator until December 1, 2026. The cohort is for early- through mid-stage medical device, diagnostic, and digital health companies. Applicants may be based anywhere but must target the U.S. market. A founder or C-suite leader must be available for the program, and companies should have clinical validation underway or in sight.
The program provides mentor matching and connections to clinical, regulatory, industry, and investor contacts. It covers commercialization, regulatory and reimbursement planning, and fundraising. Applying is free. The organizer lists a US$15,000 participation fee, with scholarships available to qualifying teams and separate terms for specialty tracks.
Selected companies do not have to relocate. They must send a co-founder or senior leader to two in-person events in California. MedTech Innovator's program director, Nicole Black, hosts applicant information sessions for the 2027 cohort.